CHEERS: PUBLIC HEALTH

Recent promotions and awards for Bloomberg School faculty

Newly recognized are in Epidemiology, Environmental Health and Engineering, International Health, and Health Policy and Management

Caleb Alexander was promoted from associate professor to professor at the December meeting of the advisory board in the Department of Epidemiology. Alexander is a pharmacoepidemiologist who specializes in prescription drug utilization, safety, and effectiveness.

Mark Bittlewas promoted from associate scientist to senior scientist at the December meeting of the advisory board in the Department of Health Policy and Management. Bittle is an expert in health care management and leadership who currently directs his department's MHA Program and its MAS in Population Health Management, an OPAL program.

Megan Latshaw, an assistant scientist in the Department of Environmental Health and Engineering, received the Distinguished Service Award for noteworthy and important contributions to environmental health from the Environment Section of the American Public Health Association at the APHA annual meeting. She works on designing healthy communities and improving environmental health surveillance. Latshaw also was elected chair of APHA's Intersectional Council Steering Committee, a group of chairs, chairs-elect, and past chairs of all the sections, including Environment. Starting next year, she will also have an ex officio seat on the APHA executive board.

Evan Mayo-Wilson was promoted from assistant scientist to associate scientist at the December meeting of the advisory board in the Department of Epidemiology. Mayo-Wilson is an epidemiologist who currently specializes in conducting, reporting, and synthesizing intervention research.

Bareng Aletta S. Nonyane was promoted from assistant scientist to associate scientist at the December meeting of the advisory board in the Department of International Health. She is a statistician whose expertise is in clustered and longitudinal data analysis, design and analysis of cluster-randomized trials, and high-dimensional data analysis. Her applications are in HIV/AIDS research, TB-related outcomes and evaluation of TB diagnostic tests, and analysis of adverse newborn outcomes.

Elizabeth Selvin, a professor in the Department of Epidemiology, has published a paper that prompted revised clinical guidelines for how diabetes is diagnosed in the United States. The paper, "Prognostic Implications of Single-Sample Confirmatory Testing for Undiagnosed Diabetes: A Prospective Cohort Study," was cited as one of the Best of 2018 in the journal Annals of Internal Medicine.

Posted in News+Info